论文信息 - Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors - 字舞流文

Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors

A. Isacchi | G. Weiss | F. Fiorentini | A. Galvani | R. Alzani | B. Valsasina | D. D. Hoff | R. Ramanathan | G. Jameson | P. Carpinelli | C. Davite | Claudia Di Giulio | A. D. Sanzo | A. Sanzo